Back to Insights

Which conditions have the fewest trials for the number of patients affected?

Research equity measures clinical trial activity relative to how many Australians live with a condition. It reveals where investment is needed most.

Research equity measures how much clinical trial activity exists relative to the estimated number of people living with a condition. A condition with many trials but few patients has high research density. A condition with many patients but few trials is a research desert. This metric helps identify where investment is needed most.

Methodology: trials per million estimated patients. Source: ClinicalTrials.gov recruiting trial counts. Australian prevalence data is not yet loaded, so this metric has not launched; it will publish once that data is in place. See the full methodology.

Research equity data is being compiled

We are cross-referencing trial counts with Australian disease prevalence estimates. This page updates automatically when the data is ready. Subscribe to be notified when it launches.

Subscribe for updates

All metrics on this page use methodology documented at /insights/methodology/. This page does not constitute medical advice.